v3.25.2
BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Schedule of Research and Development Expense [Line Items]        
Research and development $ 2,580 $ 2,899 $ 4,837 $ 5,594
Research        
Schedule of Research and Development Expense [Line Items]        
Research and development 291 336 605 720
Drug Development        
Schedule of Research and Development Expense [Line Items]        
Research and development 1,095 1,096 2,176 2,180
Other        
Schedule of Research and Development Expense [Line Items]        
Research and development $ 1,195 $ 1,467 $ 2,057 $ 2,695